Graves' disease (GD) is a common autoimmune disease (AID) that shares many of its susceptibility loci with other AIDs. The thyroid stimulating hormone receptor (TSHR) represents the primary autoantigen in GD, in which autoantibodies bind to the receptor and mimic its ligand, thyroid stimulating hormone, causing the characteristic clinical phenotype. Although early studies investigating the TSHR and GD proved inconclusive, more recently we provided convincing evidence for association of the TSHR region with disease. In the current study, we investigated a combined panel of 98 SNPs, including 70 tag SNPs, across an extended 800 kb region of the TSHR to refine association in a cohort of 768 GD subjects and 768 matched controls. In total, 28 SNPs revealed association with GD (P < 0.05), with strongest SNP associations at rs179247 (x 2 = 32.45, P = 8.90 3 10 28 , OR = 1.53, 95% CI = 1.32 -1.78) and rs12101255 (x 2 = 30.91, P = 1.95 3 10 27 , OR = 1.55, 95% CI = 1.33 -1.81), both located in intron 1 of the TSHR. Association of the most associated SNP, rs179247, was replicated in 303 GD families (P = 7.8 3 10 24 ). In addition, we provide preliminary evidence that the disease-associated genotypes of rs179247 (AA) and rs12101255 (TT) show reduced mRNA expression ratios of flTSHR relative to two alternate TSHR mRNA splice variants.
INTRODUCTION
Graves' disease (GD) is a common autoimmune disease (AID) affecting 0.5-1.0% of the general population, with autoantibodies targeting thyroid antigens (1, 2) . Genetic loci conferring risk to GD are shared among other AIDs, particularly type 1 diabetes and encode molecules vital for T cell activation and function. These include the HLA class I and class II genes on chromosome 6p21 (3, 4) , the CTLA-4 region on chromosome 2q33 (5) , the PTPN22 region on chromosome 1p13 (6) and the recently identified IL2Ra/CD25 region on chromosome 10p15 (7) . Despite a shared genetic contribution to autoimmunity, disease specific susceptibility loci are likely to contribute to the phenotypic differences between AIDs. A subject of debate in AID is the role of the target autoantigen in influencing or triggering the autoimmune process (8) .
The thyroid stimulating hormone receptor (TSHR) is expressed on the surface of thyroid follicular cells and is the primary autoantigen in GD. Although early genetic studies provided inconclusive evidence of TSHR association with GD (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , recent studies by ourselves and a Japanese group have provided more convincing evidence of association in the TSHR region (21, 22) . Previously, we analysed 20 SNPs covering a 600 kb region encompassing C14ORF145/TSHR/ GTF2A1 in a GD case-control cohort consisting of 730 multinational autoimmune thyroid disease (AITD) patients [367 Hashimoto's thyroiditis (HT) and 363 GD] and 621 controls (21) . We provided evidence for 10 single SNP associations with AITD spanning a 300 kb region around TSHR intron 1 and the neighbouring, C14ORF145, 5 0 of the TSHR itself (21) . Associations were also shown to be driven by GD and not HT patients (21) . In addition, the Wellcome Trust Case Control Consortium (WTCCC) recently provided further evidence of association of the TSHR nsSNP, rs3783941 with GD, although since this study only investigated coding SNPs, the association signal within intron 1 was not examined (23) .
Results from the previous investigations by our own group and others, strongly suggest the existence of a susceptibility locus within the TSHR region. The aim of the current study was, therefore, to refine TSHR association with GD, by analysing a panel of 98 SNPs across an extended 800 kb region of the TSHR, giving an average marker density of one SNP every 8 kb.
RESULTS

Identification of individual SNP and haplotype associations
The SNP panel consisted of 70 tag SNPs capturing most of the common genetic variation in the HapMap phase I CEU population across an extended 800 kb region of chromosome 14q31. Previously, we analysed a 600 kb region, however the analysis window was extended 100 kb 5 0 and 3 0 to ensure the association boundaries could be confidently defined. During the study, further HapMap genotype information became available (HapMap phase II) and so an additional 28 SNPs were selected to improve the amount of genetic variation captured. All SNPs were genotyped in 768 GD patients and 768 controls of UK European ancestry as described previously and all were within Hardy-Weinberg equilibrium bounds (P . 0.05) (Supplementary Material, Table S1 ) (24) . The 768 GD patients and controls investigated in the current study were independent of the AITD (consisting of both GD and HT) and control cohorts investigated previously (21) . In total, 28 SNPs revealed evidence of association with GD (P , 0.05), all of which are located within a 340 kb window spanning TSHR intron 1 and neighbouring C14ORF145 (Fig. 1) . The strongest SNP associations are all located within intron 1 of the TSHR and are separated by just 18.5 kb; these include rs179247 (x 2 = 32.45, P = 8.90 Â 10 28 , OR = 1.53, 95% CI = 1.32 -1.78), rs3783948 (x 2 = 28.50, P = 6.5 Â 10 25 , OR = 1.52, 95% CI = 1.30-1.78) and rs12101255 (x 2 = 30.91, P = 1.95 Â 10
27
, OR = 1.55, 95% CI = 1.33 -1.81) ( Table 1) . To further validate our data, the most associated SNP, rs179247, was investigated in our dataset of 303 GD families of which 160 were informative, revealing preferential transmission of the associated allele A in affected individuals, whereas unaffected family members exhibited an exactly equal transmission of alleles A and G (P = 7.80 Â 10 24 ) ( Table 2) . SNPs located within C14ORF145 also show strong evidence of association however with a slightly reduced magnitude, including rs759916 (x 2 = 24.27, P = 5.3 Â 10
26
, OR = 1.43, 95% CI = 1.23-1.67) and rs1458993 (x 2 = 21.12, P = 2.6 Â 10
25
, OR = 1.4, 95% CI = 1.20 -1.63).
Linkage disequilibrium and haplotype analysis
All linkage disequilibrium (LD) measures were calculated using the raw SNP genotype data generated in the present study. LD blocks were defined by the algorithm proposed by Gabriel et al. (25) and from each LD block haplotypes were constructed (Fig. 2) . This analysis identified 10 haplotypes all of which were located within LD blocks 5 -12 that revealed evidence of association with GD (Table 3) . Haplotype number 4 (Table 3) in LD block 7, consisting of SNPs rs179247 with the protective G allele and rs179249 with the T allele present, revealed an increased frequency in controls (0.48) compared with GD (0.38) (x 2 = 31.39, P = 2.1 Â 10
28
). Haplotype number 5, also in LD block 7, consisting of the same two SNPs with both alleles switched, rs179247 (A) and rs179249 (C), revealed an increase in frequency in GD (0.46) compared with controls (0.38) (x 2 = 19.82, P = 8.5 Â 10
26
) (Table 3) . Notably, with the exception of haplotype number 1 in LD block 5, all other major haplotype associations are located in LD blocks 7 -12, within TSHR intron 1.
The majority of individual SNP and all haplotype associations are located between LD blocks 5 and 12 which covers a 250 kb region encompassing C14ORF145 and TSHR intron 1 (Fig. 2) (Fig. 2) . Interestingly, the strongest individual SNP associations, rs179247 and rs12101255, are within LD blocks 8 and 10, respectively, which seem to be located within a 40 kb region of strong but incomplete LD (D 0 . 0.80, r 2 = 0.02 -0.98). In order to better understand the pattern of association in this region, we performed a stepwise forward logistic regression analysis to assess whether there was evidence for independent effects, as opposed to one effect driving all signals via LD. Logistic regression was performed using the PLINK software package (26) . We first tested all SNPs in the region, then re-analysed the data conditioning on the two most associated SNPs. We found that no additional SNPs remained associated after conditioning on either of the two most strongly associated SNPs (rs179247 and rs12101255). These two SNPs were each nominally significant after conditioning on the other, indicating that the causal variant is likely to be in strong, but not necessarily complete LD (r 2 = 1.00) with both of these SNPs. It is important to note that these two SNPs (rs179247 and rs12101255) share an r 2 = 0.46. On the basis of these results, it seems likely that the causal variant resides within the 40 kb region of TSHR intron 1. However, the incomplete LD and similar allele frequencies of the two most associated SNPs suggest that the causal variant is unlikely to be either of these SNPs.
Correlated expression TSHR mRNA variants with associated risk alleles
Having identified two SNPs highly associated with GD and localized within a 40 kb region of distinct LD within TSHR intron 1, we sought to determine how these associated TSHR Human Molecular Genetics, 2009, Vol. 18, No. 9 1705 
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Human Molecular Genetics, 2009, Vol. 18, No. 9 intron 1 SNPs may affect biological mechanisms that could lead to GD onset. The human TSHR transcript was first cloned in 1990 (27) . Northern blot analysis provided preliminary evidence that up to eight truncated TSHR mRNA transcripts may exist (28, 29) . By scrutinizing the literature, we identified two truncated mRNA transcripts, previously termed ST4 and ST5 that contain unique amino acid coding regions allowing them to be specifically detected by PCR (28, 29) . Primers designed specifically to ST4 and ST5 and subsequent sequencing of the PCR product confirmed their existence in a single sample of thyroid tissue (Supplementary Material, Fig. S1 ). Both ST4 and ST5 contain the first eight exons of the flTSHR and neither contains exons 9 or 10, but has unique amino acid coding regions, utilizing different parts of intron 8. Both ST4 and ST5 share the same ATG start codon as the flTSHR but have unique in frame stop codons that are spliced from the flTSHR, suggesting mRNAs might be translated, although it is possible they are degraded. We measured the expression of flTSHR, ST4 and ST5 mRNAs in 12 samples of thyroid tissue by real-time quantitative PCR, with the use of standard curves created with plasmids containing the relevant inserts for flTSHR, ST4 and ST5. In each tissue sample, we genotyped the two most highly associated SNPs (rs179247 and rs12101255) as well as one showing no association with GD (rs7145447). Using the Kruscall Wallace test, we compared the expression ratios of flTSHR:ST4 and flTSHR:ST5 with genotype of the three different SNPs. We found that genotypes of the GD-associated rs179247 were associated with disruption of the relative expression ratios of flTSHR compared with ST4 (Fig. 3) . The presence of the disease-associated AA genotype was associated with a reduced ratio of flTSHR:ST4, thus reducing the absolute amount of flTSHR mRNA compared with ST4 ( Fig. 3) . The heterozygote AG genotype increased the expression of flTSHR relative to ST4 and the GG genotype increased it still further (P = 0.02) (Fig. 3) . A similar trend of disrupted expression ratio was seen between flTSHR and ST5 for rs179247 genotypes, although not significant (P = 0.071). The other SNP highly associated with GD, rs12101255, also revealed evidence of disrupted flTSHR/ST5 mRNA expression ratios with genotype. Specifically, the GD-associated TT genotype revealed a reduced flTSHR:ST5 ratio (reduced flTSHR relative to ST5). Similar to the results of rs179247, the AT heterozygote of rs12101255 increased the expression of flTSHR relative to ST5 and CC genotype increased it even further, with P = 0.04 (Supplementary Material, Fig. S2 ). No significant difference in expression ratios was seen between flTSHR and ST4 or ST5 in the non-associated SNP (rs7145447). As a result of the relatively small number of 12 thyroid tissue samples available to us, we also attempted to measure flTSHR, ST4 and ST5 expression in peripheral blood lymphocytes from 12 GD patients, using the same methods as those employed for thyroid mRNA expression analysis. Expression of TSHR transcripts in these cells was however undetectable (data not shown but available upon request). Validation of the expression data of flTSHR ST4 and ST5 will, therefore, need to come from further thyroid tissue, currently in the process of being collected in our laboratory.
DISCUSSION
This study, including a panel of 98 SNPs capturing the majority of genetic variation in the HapMap CEU population, across a large 800 kb region of chromosome 14q31, encompassing C14ORF145-TSHR-GTF2A1-STN2 provides further evidence for association of the TSHR region with GD. Although numerous associations were identified across a wide 340 kb region, the strongest single SNP associations were detected within TSHR intron 1. Similarly, haplotype associations support these results, with the most associated haplotypes also present within this region. Logistic regression analysis suggests that two SNPs, rs179247 and rs12101255, which are part of a 40 kb region of distinct LD, account for Displays genotype counts (%) with x 2 and OR (95% confidence intervals) for three of the most highly associated SNPs, all located within the highly important 40 kb region of TSHR intron 1. TDT unaffected family members:
Human
by on August 4, 2010 all association signals identified in the region. Logistic regression was unable to split association between rs179247 and rs12101255, despite incomplete LD (D 0 = 0.92, r 2 = 0.46). Investigation of HapMap phase II data (30) reveals a number of SNPs, tagged but not investigated in the current study, in strong LD (r 2 . 0.80) with rs17927, located within 5 kb of rs179247 itself within TSHR intron 1. In the case of rs12101255, HapMap phase II data show at least four additional SNPs in strong LD (r 2 . 0.80), all located within the proposed 40 kb region, separated by just 18.5 kb from rs12101255. Although analysis of these SNPs is not only attractive but also mandatory in our attempts at identifying the GD causal variant in this region, the aim of the current study was to refine a large region of disease association based on a tag SNP strategy.
Although the current data demonstrate the strongest signals of association to be within a 40 kb region of distinct LD, we are not only limited in our ability to determine the causal variant within this region but also unable to confidently conclude whether one or more disease causing variants are located outside this region. The all important next step in the localization of disease causing variants will require comprehensive re-sequencing and extensive high throughput genotyping of all SNPs with appropriate statistical analysis in large GD sample datasets, such as those now available in UK (7, 23) . The recent advances in accurate, high throughput whole genome sequencing technologies could be implemented within this region (31, 32) , or more likely, the first data release from the 1000 genomes project (http://www.1000genomes. org/page.php) may provide the required detailed information on the location and LD patterns of all structural variants. This could reduce the need for further re-sequencing of the region and help direct the location and extent of future genotyping. This will address some of the limitations created by potential associations outside blocks of strong association and the effects of rare causal variants with high penetrance. Although exact distances may be difficult to predict, it seems likely that further mapping will need to be extended Although previous small-sized association studies proved inconclusive (9 -20) , a more recent and detailed study performed in a Japanese GD cohort investigated 22 intronic SNPs across the TSHR region and identified single SNP associations with GD primarily located within intron 7 of the TSHR (22). In the current study, we have captured the majority of common genetic variation within intron 7 and identified no evidence of association with GD in our cohort of UK European ancestry. Moreover, we directly analysed the TSHR intron 7 SNP, rs2300530, and found no evidence for association in our cohort (P = 0.70). This once again serves to highlight the presence of geographical genetic variation and the need for detailed analysis in different populations.
The recently published WTCCC non-synonymous SNP study has also replicated association between GD and the TSHR region (rs3783941) in an independent UK cohort (23). We did not type rs3783941, although it is tagged by rs3783942 (D 0 = 1.00, r 2 = 1.00), and this SNP was not associated with GD in our study (x 2 = 3.97, P = 0.14). Interestingly the initial WTCCC analysis comparing 1000 GD cases and 1500 healthy controls revealed no evidence of GD association with the TSHR nsSNP rs3783941 (23) . The larger control reference panel however used by the WTCCC, which included genotypes from three other diseases (1000 cases from each of ankylosing spondylitis, multiple sclerosis and breast cancer) in addition to the 1500 controls (4500 individuals), provided a sufficiently sized cohort for comparison with the GD cohort to detect association at rs3783941 with GD (P = 2.1 Â 10 25 ) (23). Although stringent control measures involving comparisons with the different HapMap populations were implemented to ensure all individuals were of Western European ancestry, all GD cases and controls could not be matched by exact UK geographic location, which may explain the differences observed between the WTCCC and the current study (23) .
Our preliminary TSHR mRNA expression analysis in human thyroid tissue of flTSHR and two truncated TSHR mRNA isoforms (ST4 and ST5), suggests that the highly associated SNPs (rs179247 and rs12101255) are associated with changes in expression levels of ST4 and ST5 relative to flTSHR, and may support a previously proposed hypothesis for disease pathogenesis. The TSHR protein can undergo a posttranslation intramolecular cleavage event resulting in shedding of the TSHR A-subunit. It has been suggested that this may initiate or exacerbate autoimmunity in GD. This is based on observations that TSHR autoantibodies preferentially target the extracellular A-subunit (33) and that intramuscular injection of TSHR A-subunit into a mouse model is an absolute requirement to induce the production of TSHR autoantibodies and hyperthyroidism (34) . The truncated TSHR mRNA transcripts, ST4 and ST5 investigated in the current study, possess exons 1 -8 and a ninth exon unique to each of ST4 and ST5 (retained introns) and, therefore, if translated could produce a soluble A-subunit directly. Excess mRNA expression of TSHR ST4 or ST5 may result in an increase in soluble A-subunit protein, independently of post-translational cleavage and shedding. It has been proposed that excessive A-subunit could influence autoantibody production. The expression of ST4 and ST5 would result in even higher levels of soluble A-subunit in the periphery, thus increasing the chances of autoantibody production against the TSHR. As a result, however, of limited access to thyroid tissue additional TSHR expression studies were performed on peripheral blood lymphocytes. Unfortunately, there was no evidence of expression of the different TSHR mRNA transcripts in these cells. At the present time, therefore, caution must be exercised in the interpretation of these data until further samples are able to be analysed. Moreover, although the association between the associated intron 1 SNPs and transcript expression ratios are interesting, concluding a causal link to disease is not possible until the exact disease causing DNA variants have been identified by further fine-mapping studies.
Our findings in GD highlight some of the future challenges facing association studies in all common diseases when moving from genetic association to the identification of aetiological variants. Extensive LD across the genome is likely to lead to the identification of a handful of variants with similar magnitudes of association that cannot easily be split by regression analysis. The similar effect size and magnitude of associations identified in the current study between SNPs rs179247 and rs12101255 illustrates this problem. This maybe resolved by performing future fine-mapping studies in multiple populations including, for example, those of African or recent African origin, due to the commonly observed reduced LD in these populations (35) (36) (37) . Employing such a strategy may reveal a smaller subset of SNPs with stronger association (38) . Furthermore, detailed-SNP screens such as that performed in the present study, based on common variants, are generally limited in their ability to capture genetic variation of rare SNPs, with minor allele frequencies ,5% (38) . The potential role and penetrance of such rare variants are presently unclear although, as previously mentioned, information from the 1000 genomes project and further case -control genotyping in large disease cohorts may help resolve this issue.
In summary, we provide evidence that SNPs within a 40 kb region of TSHR intron 1 are highly associated with GD in UK. Although we have not excluded an effect outside intron 1 and the mechanisms underlying the association are unclear, we have preliminary evidence to suggest that the most disease-associated SNPs could be associated with expression of the variant TSHR mRNA isoforms and hence the expression of TSHR proteins. Further genetic and functional studies are now required to identify the most important associations in this region to determine the consequences of changes in TSHR expression and the development of the autoimmune process in GD.
MATERIALS AND METHODS
Subjects
For the case -control cohort, we used 768 UK GD patients of European UK ancestry recruited from thyroid clinics in Birmingham, Bournemouth, Exeter and Walsall. GD patients were defined by the presence of biochemical hyperthyroidism
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Human Molecular Genetics, 2009, Vol. 18, No. 9 together with the presence of either thyroid eye disease (NOSPECS classification 2 -6) or with a diffuse goitre and a significant titre of microsomal, thyroglobulin or TSHR autoantibodies. Seven hundred and sixty-eight control subjects with no personal or family history of AID were recruited from various sites including the blood transfusion service, Birmingham Heartlands Hospital and Queen Elizabeth Hospital, Birmingham. All control subjects had grandparents of European UK ancestry and were age and sex matched with the GD patients. For the family analysis, 303 European UK ancestry GD patients were recruited from the same clinics, along with both parents and unaffected siblings, as described previously (39) . For TSHR mRNA isoform expression analysis, 12 samples of thyroid tissue were collected. These samples were collected at the time of thyroidectomy and were surplus to pathological requirements; all studies were performed on histologically normal European ancestry samples.
We obtained informed consent from all participant patients and the study was approved by the local Ethics Committee.
SNP selection
To define the boundaries and refine the region of association by capturing the majority genetic variation, SNP genotype information was downloaded in December 2005 (HapMap phase I) from the HapMap CEU population from an extended 800 kb region of chromosome 14. HapMap genotypes were analysed within Haploview (40) and Tag SNPs were selected using the Tagger (41) function. Seventy tag SNPs were selected with r 2 ! 0.80 to capture 80% of genotype information in the region. The average tag SNP r 2 = 0.934. During the course of the study, additional genetic information became available (HapMap phase II) and a further 28 SNPs were selected to improve the amount of genetic variation captured.
The most associated SNP, rs179247, was investigated in our family GD cohort (n = 303) to confirm association.
The two most highly associated SNPs (rs179247 and rs12101255) and one non-associated SNP (rs7145447) were selected for genotyping in our 12 thyroid samples for correlation with our gene expression data.
Genotyping
All SNP genotyping in case -control, family and expression datasets were genotyped using TaqMan w SNP genotyping chemistries (Applied Biosystems, UK). All SNPs were genotyped with a success rate .95% for all SNPs.
Total RNA extraction from thyroid tissue Total thyroid RNA was extracted after homogenization using the Tri-reagent Kit (Sigma, UK), following the manufacturers protocol, which is a single step acid guanidinium phenolchloroform extraction procedure. RNA quality was assessed spectrophotometically and cDNA quality was assessed by checking the quality of 18s amplification curves during the subsequent real-time PCR. Any samples that did not have a smooth looking amplification curve with clear early amplification, exponential and plateau phases were removed. RNA was reverse transcribed in a 20 ml reaction containing 1 mg of total RNA using the high-capacity cDNA reverse transcription kit (Applied Biosystems).
Confirming TSHR ST4 and ST5 existence
Early experiments using northern blotting procedures have suggested the existence of up to eight TSHR mRNA variants (28, 42) . Most are truncated isoforms of wild-type flTSHR with unique 3 0 -UTRs. According to Hunt et al. (42) , TSHR ST4 and ST5 reveal unique amino acid coding regions, which could be detected feasibly by PCR and sequencing. Forward primers were designed to span the TSHR exon 1 -2 boundary and reverse primers were designed in a unique amino acid coding regions of ST4 and ST5, respectively, which after sequencing of the PCR product confirmed their existence (Supplementary Material, Fig. S1 ). We found TSHR ST4 contains the first eight exons of the flTSHR, then splices 159 bp of intron 8, then utilizes the next 66 bp before a stop codon. Suggesting, the novel 66 bp on the 3 0 end is a novel exon. TSHR ST5 also utilizes the first eight exons and then splices 28 418 bp of intron 8 before utilizing the next 61 bp on its 3 0 end.
Absolute quantification by TaqMan real-time PCR
To detect flTSHR, we obtained a gene expression assay designed to span TSHR exons 9 and 10 (Applied Biosystems) (Supplementary Material, Fig. S1 ). TaqMan primers and probes specific to TSHR ST4 and ST5 were designed using primer express software w (Applied Biosystems) (Supplementary Material, Fig. S1 ).
To create a standard curve for real-time absolute quantification (aqPCR) of the flTSHR, we obtained a flTSHR clone in pcDNA3.1 (Missouri S&T cDNA resource centre). For absolute quantification of TSHR ST4 and ST5, we cloned the TaqMan PCR products into the pGEM w T-Easy plasmid, as per the manufacturers protocol (Promega, UK). All clones were grown up and maxipreped using the Genopure plasmid maxi kit using the manufacturers protocol (Roche Applied Science, UK). Each plasmid was sequenced to check the insert contained the correct sequence with no introduced mutations. Plasmid concentrations were determined using picogreen dye (invitrogen, UK) and read at A 260 on a Wallac Victor III multilabel counter (Perkin Elmer, UK). Each plasmid was diluted to a working concentration of 10 ng/ml. Eight further serial dilutions were preformed to create the standard curve with genomic DNA or plasmid DNA templates for use in quantitative PCR'). After determining the molecular weight of one plasmid, it was then possible to determine the number of plasmid copies in each dilution series. The realtime aqPCR was performed on the Applied Biosystems 7900 HT sequence detection system (Applied Biosystems). The standard curve was created in the aqPCR function of the Applied Biosystems SDS 2.2 software where each Ct-value correlates with a known quantity or copy number of plasmid. Each dilution series of the standard curve was run in triplicate, and all thyroid target samples were analysed in duplicate. For each sample, the Ct-value was normalized to the standard curve to give an absolute copy number.
Statistical analysis
All genotyping results were tested for Hardy -Weinberg equilibrium to ensure the accuracy of genotyping. Single SNP associations were tested using the x 2 -test with the statistical package MINITAB (MINITAB Release 14, #1994, Minitab Inc., PA, USA). A result was deemed significant with a P , 0.05 and all P-values were uncorrected. The transmission disequilibrium test was used to confirm association of results in our family dataset. An excess of transmissions of the associated allele from heterozygous parents to affected offspring, where P , 0.05 was taken as confirmation of association.
Pairwise D 0 and r 2 measures of LD were calculated between all SNP results within Haploview version 3.4 (40) . LD blocks were defined by the default algorithm within Haploview proposed by Gabriel et al. (25) . Logistic regression was performed using the PLINK software package (26) . We first tested all SNPs in the region, then re-analysed the data conditioning on the most associated SNP. We repeated this process once more for the only remaining associated SNP. No additional SNPs were even nominally associated after conditioning on these two.
Absolute expression values for TSHR ST4 and ST5 were compared with a ratio of the flTSHR expression values. Expression ratios of flTSHR:TSHR ST4 or flTSHR:TSHR ST5 were split by the three genotypes in five of the SNPs (rs179247, rs12101255, rs3783948, rs3783949 and rs7145447). The Kruscall Wallace test was implemented within MINITAB (MINITAB Release 14, #1994, Minitab Inc.) and used to test for significant differences between expression ratios with genotype. Differences in ratios with genotype were deemed significant with a P , 0.05.
